Article
Implementing a pharmacogenomic-driven algorithm to guide antiplatelet therapy among Caribbean Hispanics: a non-randomised clinical trial.
BMJ open - 5 Sept 2024
Nuñez-Medina Hector J, Monero Mariangeli, Torres Lorna M, Leal Enrique, Gonzalez-Sepulveda Lorena, Mayor Ángel M, Renta Jessicca Y, González-García Edgardo R, González Ariel, Melin Kyle, Scott Stuart A, Ruaño Gualberto, Hernandez-Suarez Dagmar F, Duconge Jorge
Abstract excerpt
OBJECTIVES: To assess whether genotype-guided selection of oral antiplatelet drugs using a clinical decision support (CDS) algorithm reduces the rate of major adverse cardiovascular and cerebrovascular events (MACCEs) among Caribbean Hispanic patients, after 6 months. DESIGN: An open-label, multicentre, non-randomised clinical trial. SETTING: Eight secondary and tertiary care hospitals (public and private) in...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
